Entrée Capital — 2025 Investments
6 investments dated 2025 · listed companies and verified rows first · show all
Blue Onion provides a unified financial data platform for e-commerce businesses that reconciles transaction data across multiple systems to create a single source of truth.
AI & Machine LearningE-commerceEnterprise SoftwareFintechNew York City, US
Lyndsey Bunting(Founder)inManav Malhotra(Founder)in
Co-investorsHalogen Ventures Management Company LlcViola VenturesY CombinatorVinyl CapitalViola FinTech
Cynomi offers an AI-driven security program management platform that lets managed service providers and security consultancies run assessments, generate risk registers, remediation roadmaps, policies, and compliance mappings, and manage the full security program lifecycle across their client portfolios.
AI & Machine LearningCybersecurityEnterprise SoftwareSaaS
David Primor(Co-founder and CEO)inRoy Azoulay(Co-founder and COO)inOhad Chereshniya(CFO)inShane Deegan(CRO)inErin McLean(CMO)inReut Roich(VP Product)in
Co-investorsCanaan PartnersInsight PartnersFlint CapitalLytical VenturesSelah Ventures
Freename is a Web3 domain platform where users can register, tokenize, and manage blockchain-based domains and top-level domains, with tools including Web3 emails, a website builder, DNS, domain resolution, and payment features.
Crypto & Web3Developer ToolsSaaS
Co-investorsBlockchain Founders FundGolden Record VenturesSparkle Ventures
Freename is an ICANN-accredited Web3 domain registrar that lets users register traditional and blockchain-based domains, create their own decentralized top-level domains (TLDs), and earn royalties on domains registered under them.
Crypto & Web3SaaS
Davide(CEO)
Co-investorsPolymorphic CapitalBlockchain Founders FundGolden Record VenturesSparkle Ventures
Omnix Medical is a biopharmaceutical company founded in 2015 that develops novel antibiotic agents to treat infections caused by drug-resistant bacteria.
BiotechHealthtech
Co-investorsTal VenturesOurCrowdVLX Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.